UFP Technologies, Inc. (NASDAQ:UFPT - Get Free Report) saw an uptick in trading volume on Tuesday . 33,591 shares changed hands during trading, a decline of 44% from the previous session's volume of 59,491 shares.The stock last traded at $327.06 and had previously closed at $277.62.
Wall Street Analyst Weigh In
Separately, Lake Street Capital increased their target price on UFP Technologies from $344.00 to $392.00 and gave the company a "buy" rating in a report on Wednesday, July 17th.
Get Our Latest Stock Report on UFP Technologies
UFP Technologies Price Performance
The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.63 and a current ratio of 3.13. The stock's 50 day simple moving average is $309.72 and its two-hundred day simple moving average is $289.99. The firm has a market capitalization of $2.53 billion, a PE ratio of 51.28 and a beta of 0.96.
Insider Activity
In related news, CFO Ronald J. Lataille sold 4,798 shares of UFP Technologies stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $330.44, for a total value of $1,585,451.12. Following the completion of the transaction, the chief financial officer now directly owns 41,332 shares in the company, valued at approximately $13,657,746.08. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CFO Ronald J. Lataille sold 4,798 shares of UFP Technologies stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $330.44, for a total value of $1,585,451.12. Following the completion of the transaction, the chief financial officer now owns 41,332 shares in the company, valued at $13,657,746.08. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO R Jeffrey Bailly sold 10,887 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $310.46, for a total transaction of $3,379,978.02. Following the completion of the sale, the chief executive officer now directly owns 143,970 shares in the company, valued at approximately $44,696,926.20. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 55,070 shares of company stock valued at $17,525,175. 6.17% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of UFPT. Swedbank AB purchased a new position in shares of UFP Technologies in the 1st quarter valued at approximately $25,220,000. Price T Rowe Associates Inc. MD increased its stake in UFP Technologies by 2,331.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 43,134 shares of the industrial products company's stock valued at $10,879,000 after buying an additional 41,360 shares during the period. Lord Abbett & CO. LLC raised its position in UFP Technologies by 83.1% during the 1st quarter. Lord Abbett & CO. LLC now owns 74,510 shares of the industrial products company's stock worth $18,791,000 after buying an additional 33,806 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of UFP Technologies by 5.2% in the 4th quarter. Vanguard Group Inc. now owns 533,800 shares of the industrial products company's stock worth $91,835,000 after acquiring an additional 26,269 shares during the period. Finally, Scout Investments Inc. acquired a new position in UFP Technologies during the first quarter worth $5,778,000. 87.28% of the stock is currently owned by institutional investors and hedge funds.
About UFP Technologies
(
Get Free Report)
UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.
Recommended Stories
Before you consider UFP Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UFP Technologies wasn't on the list.
While UFP Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
